Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
about
High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activationEmerging concepts in immunity to hepatitis C virus infection.Structural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell EpitopesHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferStrategies to genetically engineer T cells for cancer immunotherapy.HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer.Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitopeGeneration of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsCytotoxic CD4 T Cells-Friend or Foe during Viral Infection?Adaptive immune response during hepatitis C virus infection.Adoptive immunotherapy of cancer: Gene transfer of T cell specificity.Hepatitis C virus-mediated modulation of cellular immunity.Functional attributes of responding T cells in HCV infection: the recent advances in engineering functional antiviral T cells.Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.T-cell receptor-engineered T cells for cancer treatment: current status and future directions.Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.Protective capacity of virus-specific T cell receptor-transduced CD8 T cells in vivo.A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.
P2860
Q24324563-1D58DA98-620C-48EC-BE90-E65C817BA3B0Q27002588-5953AB95-C943-4E5A-85A6-131471A7D233Q27683638-E92648F8-718F-4023-AD50-BF3ADD2397C1Q28727481-763BD571-A4AB-4143-BCE4-6ACF12BD7DE4Q33655849-EC80D4CE-DF79-4DAE-A3B9-BC8E693DF7B3Q33735871-1EDAA16E-4E6C-412F-B97E-9200C978B105Q35274855-C493179C-0266-403D-8968-D5DE250214DAQ35960524-B082C05F-7101-4B26-8149-D9F2FB20BA5EQ36682313-E2926D57-EA23-41F9-AE14-27DCA5E285DAQ36951685-38A50284-30D9-4073-91BD-74AFB38D1EA6Q37597931-0B0D9191-0CDE-48E8-B4F9-87F6EF2FE3E7Q37682489-4A1E4F0C-16F4-4C43-9732-2BB645F412F9Q37980749-5E57990D-B802-45FB-96A7-1680C2A812AAQ38036576-F2BC1D61-0544-4248-A08F-41F3244F5512Q38129763-E82A04B9-FB23-4243-AA9F-F673D767CBE8Q38209325-669CB629-2B62-462D-9FD9-9DBC07C0EB8FQ38417056-3E27AD96-2897-416C-BC2F-66E8FB4ECFC3Q38665181-3B83E9C1-92C1-484D-9DBD-7F5E111CE655Q38767662-0A5D50EA-37A0-4C24-942E-35555148DE81Q39964234-BB89A6D3-CCB5-4741-9A04-E83E78F57B0BQ40151758-78C6BA53-0794-441A-81E0-4D8E980336D8Q42698946-9129D7F0-7EFB-4870-8BE1-77D2A3C2A1E7Q55287219-C0FFACCD-709A-49CD-BE49-3FACE655313F
P2860
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@ast
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@en
type
label
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@ast
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@en
prefLabel
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@ast
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
@en
P2093
P2860
P1433
P1476
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity
@en
P2093
Hugo R Rosen
Kelly M Moxley
Michael G Hughes
Michael I Nishimura
Mirjam H M Heemskerk
Tongxin Liu
Yeuying Liu
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001018
P577
2010-07-29T00:00:00Z